Ligand validation:8AZY

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8AZY_EDO_A_204	79%	91%	0.111	0.958	0.39	0.19	-	-	0	0	100%	1
8AZY_EDO_A_205	67%	84%	0.106	0.913	0.22	0.54	-	-	0	0	100%	1
8AZY_EDO_A_206	58%	95%	0.09	0.866	0.27	0.14	-	-	0	0	100%	1
8AZY_EDO_A_203	47%	80%	0.121	0.859	0.41	0.44	-	-	0	0	100%	1
6MBQ_EDO_A_202	97%	91%	0.059	0.971	0.34	0.23	-	-	0	0	100%	1
7MDP_EDO_I_302	65%	84%	0.126	0.927	0.47	0.29	-	-	0	0	100%	1
4DSN_EDO_A_205	41%	84%	0.135	0.85	0.47	0.3	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1
3G7R_EDO_B_961	100%	85%	0.035	0.988	0.45	0.3	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.